加巴喷丁联合血液灌流治疗血液透析病人不宁腿综合征的疗效观察

徐爱华; 高翔; 刘森炎; 钱一欣; 张玉强

doi:10.13898/j.cnki.issn.1000-2200.2017.11.017

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

加巴喷丁联合血液灌流治疗血液透析病人不宁腿综合征的疗效观察

徐爱华 , 高翔 , 刘森炎 , 钱一欣 , 张玉强

文章导航 > 蚌埠医学院学报 > 2017, 42 > 11: (1491-1494)

引用本文:

Citation:

加巴喷丁联合血液灌流治疗血液透析病人不宁腿综合征的疗效观察

1. 江苏省常州市金坛人民医院血液净化科, 213200;
2. 上海市长征医院肾内科, 200003

作者简介: 徐爱华(1969-),女,主管护师.

通讯作者: 张玉强, 主任医师.zhangyuqiang@medmail.com.cn

中图分类号: R459.5

Effect of gabapentin combined with hemoperfusion in the treatment of restless leg syndrome in hemodialysis patients

1. Department of Blood Purification, Jintan People's Hospital, Jintan Jiangsu 213200;
2. Department of Nephrology, Changzheng Hospital, Shanghai 200003, China

Corresponding author: ZHANG Yu-qiang, 主任医师.zhangyuqiang@medmail.com.cn

CLC number: R459.5

摘要: 目的：探讨加巴喷丁联合血液灌流治疗血液透析病人不宁腿综合征（RLS）的疗效。方法：选取50例维持性血液透析伴RLS病人为研究对象，随机分为2组。所有病人予常规血液透析及对症治疗；观察组病人每晚睡前口服加巴喷丁300 mg，疗程8周；并每2周给予1次血液灌流治疗。使用RLS评分量表（IRLS）评分评价病人RLS有无改善，匹兹堡睡眠质量指数评分评估治疗后病人睡眠障碍有无改善，视觉模拟（VAS）评分评价疼痛病人改善情况。并检测病人治疗前后病人血清铁蛋白、甲状旁腺素（PTH）、钙、磷等指标。结果：治疗8周后，观察组病人的RLS严重程度、PSQI和VAS评分均明显下降（P<0.01）；对照组的RLS严重程度和PSQI评分也有所下降（P<0.01），但VAS评分与治疗前比较差异无统计学意义（P>0.05）；观察组3指标的下降幅度均大于对照组（P<0.01）。治疗后2组病人铁蛋白均有所上升（P<0.01和P<0.05），PTH、Ca、P指标治疗前后无明显变化（P>0.05）。观察组病人无严重不良反应。结论：加巴喷丁联合血液灌流治疗能明显缓解病人不宁腿症状，并改善病人的睡眠质量，且没有明显不良反应。
- 不宁腿综合征 /
- 加巴喷丁 /
- 血液透析
Abstract: Objective:To investigate the effects of gabapentin combined with hemoperfusion in the treatment of restless leg syndrome(RLS) in hemodialysis patients.Methods:Fifty hemodialysis patients with RLS were randomly divided into the observation group and control group.All patients were treated with routine hemodialysis combinewd with symptomatic treatment.The observation group were additionally treated with 300 mg gabapentin by oral per night combined with blood perfusion a time every week for 8 weeks.The RLS,sleep and pain improvement in two groups were assessed using the index of RLS(IRLS),Pittsburgh Sleep Quality Index(PSQI) and Visual Analogue Scale/Score(VAS),respectively.The levels of ferritin,parathyroid hormone(PTH),Ca and P in two groups were measured before and after treatment.Results:After 8 weeks of treatment,the order of severity of IRLS,and scores of PSQI and VAS in observation group decreased significantly(P<0.01),the order of severity of IRLS,and score of PSQI in control group decreased significantly(P<0.01),but the difference of VAS score in control group was not statistically significant compared with before treatment(P>0.05).The decreasing degree of three indictors in observation group was more than that in control group(P<0.01).The levels of ferritin in two groups increased after treatment(P<0.01 and P<0.05),and the changes of the levels of PTH,Ca and P in two groups were not obvious(P>0.05).No severe adverse reaction in observation group was found.Conclusions:Gabapentin combined with hemoperfusion can significantly improve the RLS symptoms and sleep quality in hemodialysis patients,which has no significant adverse reaction.
- restless leg syndrome /
- gabapentin /
- hemodialysis

[1]	GIANNAKI CD,HADJIGEORGIOU GM,KARATZAFERI C,et al.Epidemiology,impact,and treatment options of restless legs syndrome in end-stage renal disease patients:an evidence-based review[J].Kidney Int,2014,85(6):1275.
[2]	LA MANNA G,PIZZA F,PERSICI E,et al.Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment[J].Nephrol Dial Transplant,2011,26(6):1976.
[3]	PICCHIETTI DL,HENSLEY JG,BAINBRIDGE JL,et al.Consensus clinical practice guidelines for the diagnosis and treatment of restless legs syndrome/Willis-Ekbom disease during pregnancy and lactation[J].Sleep Med Rev,2015,22:64.
[4]	WIJEMANNE S,ONDO W.Restless Legs Syndrome:clinical features,diagnosis and a practical approach to management[J].Pract Neurol,2017,17(6):444.
[5]	FERRI R,KOO BB,PICCHIETTI DL,et al.Periodic leg movements during sleep:phenotype,neurophysiology,and clinical significance[J].Sleep Med,2017,31:29.
[6]	NEVES PD,GRACIOLLI FG,OLIVEIRA IB,et al.Effect of Mineral and Bone Metabolism on Restless Legs Syndrome in Hemodialysis Patients[J].J Clin Sleep Med,2017,13(1):89.
[7]	MARCONI S,SCAGLIONE C,PIZZA F,et al.Group I nonreciprocal inhibition in restless legs syndrome secondary to chronic renal failure[J].Parkinsonism Relat Disord,2012,18(4):362.
[8]	GIANNAKI CD,SAKKAS GK,KARATZAFERI C,et al.Effect of exercise training and dopamine agonists in patients with uremic restless legs syndrome:a six month randomized,partially double-blind,placebo-controlled comparative study[J].BMC Nephrol,2013,14:1.
[9]	KIM ES,DEEKS ED.Gabapentin Enacarbil:A Review in Restless Legs Syndrome[J].Drugs,2016,76(8):879.
[10]	DENG Y,WU J,JIA Q.Efficacy of intravenous iron sucrose in hemodialysis patients with restless legs syndrome (RLS):a randomized,placebo-controlled study[J].Med Sci Monit,2017,23:1254.

[1]	仲丽丽 . 血液透析联合血液灌流治疗尿毒症并发不宁腿综合征及睡眠障碍的护理. 蚌埠医学院学报, 2013, 37(12): 1673-1675.
[2]	李庆士 , 孙静静 , 李龙海 . 加巴喷丁治疗腹膜透析病人皮肤瘙痒的疗效及安全性观察. 蚌埠医学院学报, 2022, 47(6): 776-778. doi: 10.13898/j.cnki.issn.1000-2200.2022.06.018
[3]	周锡芳 . 血液透析室医院感染18例护理体会. 蚌埠医学院学报, 2011, 36(11): 1279-1281.
[4]	李彩 . 血液透析护理体会(附20例报道). 蚌埠医学院学报, 2008, 33(4): 486-487.
[5]	索文丽 . 老年尿毒症患者血液透析护理体会. 蚌埠医学院学报, 2009, 34(5): 438-440.
[6]	陈忠辉 , 何静 . 维持性血液透析患者血管钙化相关因素研究. 蚌埠医学院学报, 2016, 41(9): 1207-1210. doi: 10.13898/j.cnki.issn.1000-2200.2016.09.028
[7]	倪龙根 . 丙型肝炎病毒感染与血液透析的关系. 蚌埠医学院学报, 2004, 29(1): 92-94.
[8]	高潮清 , 周加军 . 血液透析与腹膜透析对尿毒症病人钙磷代谢的影响比较. 蚌埠医学院学报, 2017, 42(4): 472-473,476. doi: 10.13898/j.cnki.issn.1000-2200.2017.04.016
[9]	马逸宜 , 蒋燕东 . 超声引导下颈内静脉置管在血液透析中的应用. 蚌埠医学院学报, 2014, 38(3): 383-384.
[10]	凌琳 , 赵丽丽 . 治疗性沟通在诱导期血液透析患者焦虑中的运用. 蚌埠医学院学报, 2014, 39(8): 1129-1131.
[11]	王敬 . 血液透析诱发心房颤动的临床特点及治疗分析. 蚌埠医学院学报, 2011, 36(10): 1094-1096.
[12]	洪世琼 . 首次血液透析患者并发症的预防及护理. 蚌埠医学院学报, 2012, 36(1): 105-107.
[13]	毛诗海 , 程训民 , 杨松 , 葛玲 , 崔杰西 . 尿毒症维持性血液透析患者超敏C反应蛋白检测临床应用. 蚌埠医学院学报, 2012, 36(3): 292-293.
[14]	李斌 . 维持性血液透析患者发生心血管疾病危险因素分析. 蚌埠医学院学报, 2013, 37(8): 967-969.
[15]	何丽芳 , 甘香 , 杨莺卿 , 刘美全 . 中青年维持性血液透析患者压力源的质性研究. 蚌埠医学院学报, 2013, 37(12): 1620-1622,1630.
[16]	徐文蔚 , 毛佩菊 , 刘欣颖 . 血液透析患者瘦素水平与胰岛素抵抗的关系研究. 蚌埠医学院学报, 2009, 34(5): 392-394.
[17]	骆玉乔 . 维持性血液透析患者动静脉内瘘闭塞17例护理体会. 蚌埠医学院学报, 2012, 36(9): 1135-1137.
[18]	刁秀竹 , 陈薇 . 维持性血液透析动静脉内瘘并发症防治. 蚌埠医学院学报, 2010, 35(3): 273-275.
[19]	李虹 , 常保超 , 张玮 , 刘丽 . 血液透析中进食时间对患者血压的影响分析. 蚌埠医学院学报, 2014, 39(11): 1577-1579.
[20]	张晓元 . 血液透析过程中的低血压现象分析及防治. 蚌埠医学院学报, 2004, 29(2): 163-164.

点击查看大图

计量

文章访问数: 2879
HTML全文浏览量: 478
PDF下载量: 57
被引次数: 0

加巴喷丁联合血液灌流治疗血液透析病人不宁腿综合征的疗效观察

通讯作者: 张玉强, 主任医师.zhangyuqiang@medmail.com.cn

作者简介: 徐爱华(1969-),女,主管护师.

1. 江苏省常州市金坛人民医院血液净化科, 213200;
2. 上海市长征医院肾内科, 200003

收稿日期: 2016-12-28

关键词:

摘要: 目的：探讨加巴喷丁联合血液灌流治疗血液透析病人不宁腿综合征（RLS）的疗效。方法：选取50例维持性血液透析伴RLS病人为研究对象，随机分为2组。所有病人予常规血液透析及对症治疗；观察组病人每晚睡前口服加巴喷丁300 mg，疗程8周；并每2周给予1次血液灌流治疗。使用RLS评分量表（IRLS）评分评价病人RLS有无改善，匹兹堡睡眠质量指数评分评估治疗后病人睡眠障碍有无改善，视觉模拟（VAS）评分评价疼痛病人改善情况。并检测病人治疗前后病人血清铁蛋白、甲状旁腺素（PTH）、钙、磷等指标。结果：治疗8周后，观察组病人的RLS严重程度、PSQI和VAS评分均明显下降（P<0.01）；对照组的RLS严重程度和PSQI评分也有所下降（P<0.01），但VAS评分与治疗前比较差异无统计学意义（P>0.05）；观察组3指标的下降幅度均大于对照组（P<0.01）。治疗后2组病人铁蛋白均有所上升（P<0.01和P<0.05），PTH、Ca、P指标治疗前后无明显变化（P>0.05）。观察组病人无严重不良反应。结论：加巴喷丁联合血液灌流治疗能明显缓解病人不宁腿症状，并改善病人的睡眠质量，且没有明显不良反应。

English Abstract

Effect of gabapentin combined with hemoperfusion in the treatment of restless leg syndrome in hemodialysis patients

Corresponding author: ZHANG Yu-qiang, 主任医师.zhangyuqiang@medmail.com.cn

1. Department of Blood Purification, Jintan People's Hospital, Jintan Jiangsu 213200;
2. Department of Nephrology, Changzheng Hospital, Shanghai 200003, China

Received Date: 2016-12-28

Abstract: Objective:To investigate the effects of gabapentin combined with hemoperfusion in the treatment of restless leg syndrome(RLS) in hemodialysis patients.Methods:Fifty hemodialysis patients with RLS were randomly divided into the observation group and control group.All patients were treated with routine hemodialysis combinewd with symptomatic treatment.The observation group were additionally treated with 300 mg gabapentin by oral per night combined with blood perfusion a time every week for 8 weeks.The RLS,sleep and pain improvement in two groups were assessed using the index of RLS(IRLS),Pittsburgh Sleep Quality Index(PSQI) and Visual Analogue Scale/Score(VAS),respectively.The levels of ferritin,parathyroid hormone(PTH),Ca and P in two groups were measured before and after treatment.Results:After 8 weeks of treatment,the order of severity of IRLS,and scores of PSQI and VAS in observation group decreased significantly(P<0.01),the order of severity of IRLS,and score of PSQI in control group decreased significantly(P<0.01),but the difference of VAS score in control group was not statistically significant compared with before treatment(P>0.05).The decreasing degree of three indictors in observation group was more than that in control group(P<0.01).The levels of ferritin in two groups increased after treatment(P<0.01 and P<0.05),and the changes of the levels of PTH,Ca and P in two groups were not obvious(P>0.05).No severe adverse reaction in observation group was found.Conclusions:Gabapentin combined with hemoperfusion can significantly improve the RLS symptoms and sleep quality in hemodialysis patients,which has no significant adverse reaction.